US Stock MarketDetailed Quotes

MBOT Microbot Medical

Watchlist
  • 1.010
  • -0.010-0.98%
Close Jul 1 16:00 ET
  • 0.981
  • -0.029-2.86%
Post 19:57 ET
16.13MMarket Cap-1174P/E (TTM)

Microbot Medical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
24.45%-2.42M
26.11%-8.53M
26.07%-1.82M
43.99%-1.66M
40.65%-1.85M
-6.52%-3.2M
-23.47%-11.55M
14.69%-2.46M
-35.80%-2.96M
-36.00%-3.12M
Net income from continuing operations
16.89%-2.37M
18.44%-10.74M
-5.20%-3.15M
29.47%-2.45M
34.90%-2.29M
10.54%-2.85M
-16.40%-13.17M
22.31%-3M
-35.73%-3.47M
-39.90%-3.51M
Operating gains losses
----
-60.00%2K
----
----
----
----
--5K
----
----
----
Depreciation and amortization
12.00%28K
3.92%106K
6.06%35K
-20.00%20K
13.04%26K
19.05%25K
34.21%102K
17.86%33K
56.25%25K
64.29%23K
Other non cash items
----
6,066.67%716K
--821K
---70K
---8K
-2,800.00%-27K
---12K
----
----
--0
Change In working capital
30.26%-530K
95.18%-11K
125.32%178K
1,703.57%505K
200.00%66K
-182.53%-760K
-145.88%-228K
-86.21%79K
-50.00%28K
32.65%-66K
-Change in prepaid assets
-377.86%-389K
5,069.23%672K
136.50%123K
-23.26%231K
239.06%178K
-20.90%140K
-92.66%13K
-865.91%-337K
634.15%301K
-2,460.00%-128K
-Change in payables and accrued expense
58.22%-376K
-183.40%-683K
-86.78%55K
200.37%274K
-280.65%-112K
-101.79%-900K
-175.31%-241K
-21.36%416K
-1,920.00%-273K
166.67%62K
-Change in other working capital
--235K
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
24.45%-2.42M
26.11%-8.53M
26.07%-1.82M
43.99%-1.66M
40.65%-1.85M
-6.52%-3.2M
-23.47%-11.55M
14.69%-2.46M
-35.80%-2.96M
-36.00%-3.12M
Investing cash flow
Cash flow from continuing investing activities
-144.54%-1.28M
151.43%1.97M
178.79%2.96M
-51,340.00%-2.57M
-1,988.71%-1.3M
18,118.75%2.88M
-219.88%-3.84M
-227.01%-3.75M
64.29%-5K
-933.33%-62K
Net PPE purchase and sale
---14K
60.71%-33K
400.00%3K
-420.00%-26K
83.87%-10K
--0
-21.74%-84K
97.73%-1K
64.29%-5K
-933.33%-62K
Net investment purchase and sale
-144.05%-1.27M
153.46%2.01M
178.73%2.95M
---2.55M
---1.29M
--2.88M
-214.78%-3.75M
-225.11%-3.75M
--0
--0
Cash from discontinued investing activities
Investing cash flow
-144.54%-1.28M
151.43%1.97M
178.79%2.96M
-51,340.00%-2.57M
-1,988.71%-1.3M
18,118.75%2.88M
-219.88%-3.84M
-227.01%-3.75M
64.29%-5K
-933.33%-62K
Financing cash flow
Cash flow from continuing financing activities
2.4M
51.67%6.56M
0
-161K
6.72M
0
4.32M
4.32M
0
Net common stock issuance
--2.4M
51.67%6.56M
--0
---161K
--6.72M
--0
--4.32M
--4.32M
--0
----
Cash from discontinued financing activities
Financing cash flow
--2.4M
51.67%6.56M
--0
---161K
--6.72M
--0
--4.32M
--4.32M
--0
----
Net cash flow
Beginning cash position
-0.08%2.52M
-81.45%2.52M
-68.69%1.38M
-21.73%5.77M
-79.17%2.2M
-81.45%2.52M
-31.18%13.58M
-67.35%4.41M
-53.06%7.37M
-41.37%10.56M
Current changes in cash
-308.44%-1.31M
99.98%-2K
160.04%1.14M
-48.24%-4.39M
212.05%3.57M
89.41%-320K
-79.74%-11.06M
-2,882.35%-1.89M
-35.16%-2.96M
-38.34%-3.19M
End cash Position
-44.97%1.21M
-0.08%2.52M
-0.08%2.52M
-68.69%1.38M
-21.73%5.77M
-79.17%2.2M
-81.45%2.52M
-81.45%2.52M
-67.35%4.41M
-53.06%7.37M
Free cash flow
24.01%-2.43M
26.36%-8.57M
26.30%-1.82M
43.14%-1.68M
41.49%-1.86M
-5.95%-3.2M
-23.45%-11.63M
15.93%-2.46M
-35.16%-2.96M
-38.34%-3.19M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 24.45%-2.42M26.11%-8.53M26.07%-1.82M43.99%-1.66M40.65%-1.85M-6.52%-3.2M-23.47%-11.55M14.69%-2.46M-35.80%-2.96M-36.00%-3.12M
Net income from continuing operations 16.89%-2.37M18.44%-10.74M-5.20%-3.15M29.47%-2.45M34.90%-2.29M10.54%-2.85M-16.40%-13.17M22.31%-3M-35.73%-3.47M-39.90%-3.51M
Operating gains losses -----60.00%2K------------------5K------------
Depreciation and amortization 12.00%28K3.92%106K6.06%35K-20.00%20K13.04%26K19.05%25K34.21%102K17.86%33K56.25%25K64.29%23K
Other non cash items ----6,066.67%716K--821K---70K---8K-2,800.00%-27K---12K----------0
Change In working capital 30.26%-530K95.18%-11K125.32%178K1,703.57%505K200.00%66K-182.53%-760K-145.88%-228K-86.21%79K-50.00%28K32.65%-66K
-Change in prepaid assets -377.86%-389K5,069.23%672K136.50%123K-23.26%231K239.06%178K-20.90%140K-92.66%13K-865.91%-337K634.15%301K-2,460.00%-128K
-Change in payables and accrued expense 58.22%-376K-183.40%-683K-86.78%55K200.37%274K-280.65%-112K-101.79%-900K-175.31%-241K-21.36%416K-1,920.00%-273K166.67%62K
-Change in other working capital --235K------------------------------------
Cash from discontinued investing activities
Operating cash flow 24.45%-2.42M26.11%-8.53M26.07%-1.82M43.99%-1.66M40.65%-1.85M-6.52%-3.2M-23.47%-11.55M14.69%-2.46M-35.80%-2.96M-36.00%-3.12M
Investing cash flow
Cash flow from continuing investing activities -144.54%-1.28M151.43%1.97M178.79%2.96M-51,340.00%-2.57M-1,988.71%-1.3M18,118.75%2.88M-219.88%-3.84M-227.01%-3.75M64.29%-5K-933.33%-62K
Net PPE purchase and sale ---14K60.71%-33K400.00%3K-420.00%-26K83.87%-10K--0-21.74%-84K97.73%-1K64.29%-5K-933.33%-62K
Net investment purchase and sale -144.05%-1.27M153.46%2.01M178.73%2.95M---2.55M---1.29M--2.88M-214.78%-3.75M-225.11%-3.75M--0--0
Cash from discontinued investing activities
Investing cash flow -144.54%-1.28M151.43%1.97M178.79%2.96M-51,340.00%-2.57M-1,988.71%-1.3M18,118.75%2.88M-219.88%-3.84M-227.01%-3.75M64.29%-5K-933.33%-62K
Financing cash flow
Cash flow from continuing financing activities 2.4M51.67%6.56M0-161K6.72M04.32M4.32M0
Net common stock issuance --2.4M51.67%6.56M--0---161K--6.72M--0--4.32M--4.32M--0----
Cash from discontinued financing activities
Financing cash flow --2.4M51.67%6.56M--0---161K--6.72M--0--4.32M--4.32M--0----
Net cash flow
Beginning cash position -0.08%2.52M-81.45%2.52M-68.69%1.38M-21.73%5.77M-79.17%2.2M-81.45%2.52M-31.18%13.58M-67.35%4.41M-53.06%7.37M-41.37%10.56M
Current changes in cash -308.44%-1.31M99.98%-2K160.04%1.14M-48.24%-4.39M212.05%3.57M89.41%-320K-79.74%-11.06M-2,882.35%-1.89M-35.16%-2.96M-38.34%-3.19M
End cash Position -44.97%1.21M-0.08%2.52M-0.08%2.52M-68.69%1.38M-21.73%5.77M-79.17%2.2M-81.45%2.52M-81.45%2.52M-67.35%4.41M-53.06%7.37M
Free cash flow 24.01%-2.43M26.36%-8.57M26.30%-1.82M43.14%-1.68M41.49%-1.86M-5.95%-3.2M-23.45%-11.63M15.93%-2.46M-35.16%-2.96M-38.34%-3.19M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg